CDH17 and cancer: The overexpression of cadherins in several types of cancer cells compared to the remaining non-tumoral tissues and their role in the permeation of biological barriers through the paracellular pathway have also opened the possibility of exploring them as receptors for targeted drug delivery [54,55,56].